What is the Y-tunnus number of BBS-Bioactive Bone Substitutes Oyj?

BBS-Bioactive Bone Substitutes Oyj is registered with PRH / YTJ under Y-tunnus 0866451-4.

How many employees does BBS-Bioactive Bone Substitutes Oyj have?

BBS-Bioactive Bone Substitutes Oyj employs 3 people as of the latest annual report.

Juliusz Henrik Tadeusz Rakowski is the CEO of BBS-Bioactive Bone Substitutes Oyj, in role since 2023.

Pekka Kalevi Aleksanteri Jalovaara chairs the board of BBS-Bioactive Bone Substitutes Oyj, in role since 2023.

BBS-Bioactive Bone Substitutes Oyj's registered address is Kiviharjunlenkki 6.

OYJBankrupt

Y-tunnus 0866451-4Kiviharjunlenkki 6, 90220 OuluResearch and experimental development on natural sciences and engineering· NACE 7210Est. 1991 · 35 years old3 employees

Actively employed in the business

Name	Role	Member since
Current (1)
JH Juliusz Henrik Tadeusz Rakowski Chief Executive Officer	Chief Executive Officer	2023
Former (4)
IM Ilkka Martti Olavi Kangasniemi Chief Executive Officer	Chief Executive Officer	2019 – 2023
MJ Milla Johanna Karjalainen Deputy auditor	Deputy auditor	2020 – 2021
MJ Markku Juhani Rönkkö Audit	Audit	2017 – 2020
JP Jari Petteri Karppinen Audit	Audit	2020 – 2023

Non-executive oversight

Name	Role	Member since
Current (5)
GH Gregor Heinrich Siebert Board of Directors	Board of Directors	2024
JO Jarmo Olavi Halonen Board of Directors	Board of Directors	2023
PK Pekka Kalevi Aleksanteri Jalovaara Chairperson	Chairperson	2023
SJ Seppo Juhani Nevalainen Board of Directors	Board of Directors	2020
KP Kirk Patrick Andriano Board of Directors	Board of Directors	2021
Former (4)
AA Auvo Antero Juhani Kaikkonen Board of Directors	Board of Directors	2018 – 2020
HO Hannu Olavi Säynäjäkangas Board of Directors	Board of Directors	2018 – 2020
TJ Tomi Juhani Numminen Board of Directors	Board of Directors	2018 – 2021
AP Ahti Petteri Paananen Board of Directors	Board of Directors	2022 – 2024

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.